Singapore: IPOS lowers filing fees for IP protection

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Singapore: IPOS lowers filing fees for IP protection

The Intellectual Property Office of Singapore (IPOS) announced last month that the fees for patent search and examination reports and for trade mark applications will be reduced effective April 1 2017.

Requests for patent search and examination reports where the International Search Report or International Preliminary Examination Report has been established by IPOS under the Patents Cooperation Treaty (PCT) will see the largest decrease of 37%. IPOS has been acting as International Searching Authority (ISA) and International Preliminary Examining Authority (IPEA) under the PCT since September 1 2015.

Patent applications where IPOS has not acted as ISA or IPEA will also see a fee decrease of 25% for requests for patent search and examination reports.

IPOS states that the announced fee decrease is part of the Office's efforts to support Singapore's innovators and make IP protection more affordable, in keeping with its vision to help drive innovation in Singapore.

While announcing the reduction in patent filing fees, IPOS also announced the introduction of an excess claim fee of S$40 ($28) per claim in excess of 20 claims from April 2017. The excess claim fee will apply when filing a request for examination and during payment of the grant fee.

According to IPOS, the implementation of the excess claim fee will help reduce the current burden on patent examiners. IPOS also observed that the average patent application has around 18 claims and thus they do not expect the excess claim fee to apply to most applicants.

Voluntary amendments can be made in Singapore any time before a request for examination has been made. In addition, it is important to note that Singapore accepts multiple dependent claims and, unlike other jurisdictions, it is permissible in Singapore for multiple dependent claims to refer to other multiple dependent claims. Accordingly, one should take advantage of such claim dependencies to cover important combinations of features or secondary inventive embodiments.

Despite the excess claim fee being paid at the time of requesting examination, IPOS would still require payment on excess claims when the patent application becomes granted. However, the excess claim fee payment at grant only applies to claims over and above those paid for during examination stage.

In addition to revision of patent fees, IPOS will reduce fees for applying for trade marks using a pre-approved list of goods and services by 30%.

IPOS Chief Executive Daren Tang said: "Singapore's innovation scene is becoming more vibrant, with more companies and start-ups seeking to create business value through IP. The fee revisions make it easier and cheaper for them to protect their brands and technology. We hope that more of our creative enterprises and inventors will be encouraged by these changes to have a strong foundation for taking their ideas to the world."

With the fees adjustment on April 1 2017, Singapore remains one of the most attractive countries for IP filing, with competitive rates compared to other major jurisdictions.

Maximilian Stelzer

Edwin Dai


Spruson & Ferguson (Asia) Pte Ltd152 Beach Road#37-05/06 Gateway EastSingapore 189721Tel: +65 6333 7200Fax: +65 6333 7222mail.asia@spruson.comwww.spruson.com

more from across site and SHARED ros bottom lb

More from across our site

Licensing chief Patrik Hammarén also reveals that the company will rename its IPR business to better reflect its role in defining standards
The acquisition of Pecher & Partners follows the firm’s earlier expansion into litigation to create a ‘one-stop shop’
News of Via Licensing Alliance launching its first semiconductor patent pool and INTA electing a new president were also among the top talking points
Submit your nominations to this year's WIBL Americas Awards by January 23
The 2026 Life Sciences EMEA Awards is now open for entries. We are looking forward to reviewing and celebrating the industry's most impressive achievements and landmarks from the past year.
The tie-up between Perkins Coie and Ashurst may generate some striking numbers, but independent IP firms need not worry yet, according to practitioners
Perkins Coie’s US patent prosecution strength could provide Ashurst with an opportunity to enter an untapped market in Australia, but it may not be easy
Mitesh Patel at Reed Smith outlines why the US Copyright Office and courts have so far dismissed AI authorship and how inventors can protect AI-generated works
Xia Zheng, founder of AFD China, discusses balancing legal work with BD, new approaches to complex challenges, and the dangers of ‘over-optimism’
A dispute involving semiconductor technology and a partner's move from Hoffman Eitle to Hoyng Rokh Monegier were also among the top talking points
Gift this article